These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29046738)

  • 21. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
    Messick CA; Kravochuck S; Church JM; Kalady MF
    Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
    Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.
    Bleijenberg AG; IJspeert JE; van Herwaarden YJ; Carballal S; Pellisé M; Jung G; Bisseling TM; Nagtegaal ID; van Leerdam ME; van Lelyveld N; Bessa X; Rodríguez-Moranta F; Bastiaansen B; de Klaver W; Rivero L; Spaander MC; Koornstra JJ; Bujanda L; Balaguer F; Dekker E
    Gut; 2020 Jan; 69(1):112-121. PubMed ID: 30981990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
    Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
    Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
    Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
    Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation.
    Stuckless S; Green JS; Morgenstern M; Kennedy C; Green RC; Woods MO; Fitzgerald W; Cox J; Parfrey PS
    Clin Genet; 2012 Nov; 82(5):439-45. PubMed ID: 22011075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Features of incident colorectal cancer in Lynch syndrome.
    Argillander TE; Koornstra JJ; van Kouwen M; Langers AM; Nagengast FM; Vecht J; de Vos Tot Nederveen Cappel WH; Dekker E; van Duijvendijk P; Vasen HF
    United European Gastroenterol J; 2018 Oct; 6(8):1215-1222. PubMed ID: 30288284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.
    Jenkins MA; Dowty JG; Ait Ouakrim D; Mathews JD; Hopper JL; Drouet Y; Lasset C; Bonadona V; Win AK
    J Clin Oncol; 2015 Feb; 33(4):326-31. PubMed ID: 25534380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the appropriate screening protocol in Lynch syndrome?
    de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
    Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.
    Click B; Pinsky PF; Hickey T; Doroudi M; Schoen RE
    JAMA; 2018 May; 319(19):2021-2031. PubMed ID: 29800214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
    Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
    Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal benefit of earlier-than-recommended repeat colonoscopy among US Medicare enrollees following a negative colonoscopy.
    Yang YX; French B; Localio AR; Brensinger CM; Lewis JD
    Aliment Pharmacol Ther; 2014 Oct; 40(7):843-53. PubMed ID: 25123489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
    Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
    Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer.
    Stormorken AT; Clark N; Grindedal E; Maehle L; Møller P
    Scand J Gastroenterol; 2007 May; 42(5):611-7. PubMed ID: 17454882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.
    Valentín F; Guarinos C; Juárez M; Rodríguez-Soler M; Serradesanferm A; Rodriguez-Moranta F; Nicolas-Perez D; Bujanda L; Herraiz M; De-Castro L; Fernández-Bañares F; Herreros-de-Tejada A; Martínez F; Aguirre E; Ferrández Á; Díaz-Tasende J; Piñol V; Paya A; Egoavil C; Alenda C; Castells A; Jover R; Cubiella J
    Endoscopy; 2016 Jan; 48(1):56-61. PubMed ID: 26165738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.